Chethana Medicaments Pvt Ltd, a active private limited company, was established on 10 January 1994 in Malappuram, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51397KL1994PTC007632. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.54 M.
It upholds a compliant status. Its leadership includes Avanoormana Damodaran Nambudiri (Whole-Time Director), Narayanan Avanoor Mana (Director), Kunnakkavu Puthumana Purushothaman (Managing Director). Past directors included Vancheri Namboothiri Narayanan Namboothiri, Saraswathy Vancheri Narayanan. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at 5/345Ambalakatt Road Perinthalmanna, Malappuram, Kerala, 679322.
U51397KL1994PTC007632
007632
10 January 1994
₹1.00 M
₹0.54 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Chethana Medicaments Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avanoormana Damodaran Nambudiri | Whole-Time Director | 10 Jan 1994 | Current |
| Narayanan Avanoor Mana | Director | 01 Nov 1995 | Current |
| Kunnakkavu Puthumana Purushothaman | Managing Director | 10 Jan 1994 | Current |
| Saraswathy Vancheri Narayanan | Director | 17 Jun 2019 | Current |
| Damodar Avanoor | Whole-Time Director | 10 Jan 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chethana Medicaments Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.48% decrease. The company also saw a substantial fall in profitability, with a 35.4% decrease in profit. The company's net worth Soared by an impressive increase of 37.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Chethana Medicaments had a promoter holding of 59.83% and a public holding of 40.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Dhanlaxmi Bank Limited | ₹0.35 M | Open |
| 24 Sep 2018 | Dhanlaxmi Bank Limited | ₹2.00 M | Open |
| 11 Nov 1995 | Dhanalakshmi | ₹0.15 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Chethana Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Chethana Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chethana Medicaments's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chethana Medicaments Pvt Ltd last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
The activity Chethana Medicaments Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
The activity A charge with Dhanlaxmi Bank Limited amounted to Rs. 0.35 M with Charge ID 100380526 was registered on 27 Jul 2020. was completed.
Saraswathy Vancheri Narayanan was appointed as a Director was appointed as a Director on 17 Jun 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
The activity A charge with Dhanlaxmi Bank Limited amounted to Rs. 2.00 M with Charge ID 100240335 was registered on 24 Sep 2018. was completed.
A charge with Dhanalakshmi amounted to Rs. 0.15 M with Charge ID 90016476 was registered on 11 Nov 1995. was recorded as a recent event.
The CIN of Chethana Medicaments Pvt Ltd is U51397KL1994PTC007632.
Chethana Medicaments Pvt Ltd is headquartered at 5/345Ambalakatt Road Perinthalmanna, Malappuram, Kerala, 679322.
Chethana Medicaments Pvt Ltd was incorporated on 10 January 1994.
The current directors of Chethana Medicaments Pvt Ltd are
The primary industry of Chethana Medicaments Pvt Ltd is Trade.
Chethana Medicaments Pvt Ltd is unlisted.
The authorized capital of Chethana Medicaments Pvt Ltd is ₹1.00 M, and the paid-up capital is ₹0.54 M.
The compliance status of Chethana Medicaments Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX